🇺🇸 FDA

Drug profile · INN

rabeprazole sodium

RABEPRAZOLE SODIUM

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

rabeprazole sodium (RABEPRAZOLE SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN rabeprazole sodium
Brand RABEPRAZOLE SODIUM
Route ORAL
Formulation TABLET, DELAYED RELEASE

Frequently asked questions

What is rabeprazole sodium?

rabeprazole sodium (RABEPRAZOLE SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for rabeprazole sodium?

RABEPRAZOLE SODIUM is a marketed brand name for rabeprazole sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of rabeprazole sodium?

rabeprazole sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.